Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Ribo Life Science realises series C2 round
SAIC Motor fund Hengxu Investment and a Sinopharm-backed joint venture were among the investors in a $66.3m round for the RNA drug developer.
Zentalis zips to $165m IPO
The Pharamron-backed oncology drug developer floated at the top of its range while increasing the number of shares in the offering.
Legend Biotech lands $151m
Lilly Asia Ventures and Johnson & Johnson Innovation – JJDC are both investing in a series A round for the cell therapy developer, a spinoff from Genscript Biotech.
Narwal Robotics dives into series B round
Digital media company Bytedance has co-led a $14.1m round for Narwal Robotics, which produces autonomous floor cleaning robots.
Seegrid gets $25m from G2VP
Seegrid, which counts Giant Eagle as its largest investor, has received funding from venture firm G2VP at a nine-figure valuation.
Phantom AI scares up $22m
Ford Motor and KT both contributed to a series A round that increased the total raised by the driver assistance technology developer to $27m.
Corporate venturing deal net: 30 March-3 April 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
AM-Pharma amplifies latest round to $182m
Cowen and European Investment Bank added $52m to a $130m first tranche closed by the AbbVie and Pfizer-backed kidney injury drug developer in July.

News Continued

6 Dimensions supports $125m round for iTeos
The WuXi-backed investment firm returned for a series B2 round that will support phase 1/2 trials for iTeos Therapeutics' oncology therapies.
Pandion packs in $80m
Autoimmune disease drug developer Pandion Therapeutics closed a series B round co-led by Access Biotechnology and backed by Roche Venture Fund and SR One.
Collibra collects $112m
CapitalG returned for a late-stage round that pushed Collibra’s total funding beyond $345m and boosted its valuation to $2.3bn.
Aspen Neuroscience ascends with $70m
The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.
Orion Labs organises $29m series B
The enterprise communication platform developer has now raised more than $62m altogether, Dell Technologies Capital leading its latest round.
4Paradigm fixes $230m in funding
Cisco and Lenovo helped the artificial intelligence software producer hike its valuation from $1.2bn to $2bn, following a $145m round in 2018.

Editor's Picks

Exor mobilises $200m for Via Transportation
Transportation services provider Via raised the money as part of a series E round also featuring Shell, Hearst Ventures and Mori Building valuing it at $2.25bn.
Letgo links to OfferUp in merger deal
Naspers subsidiary OLX Group led a $120m round for the e-commerce app developers, which have agreed to merge, and will own 40% of the combined entity.
Gojek carts away $1.2bn
Unnamed investors have added $1.2bn to a round already featuring AIA, Mitsubishi, Visa, SCB, Astra International, Tencent, and Google that reportedly now totals near $3bn.
Beike Zhaofang moves to $2.4bn round
SoftBank reportedly invested $1bn in the online real estate brokerage as part of a $2.41bn round also featuring Tencent at a valuation of more than $14bn.
test reg